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The role of the center of the immunological synapse
(the central supramolecular activation cluster or
cSMAC) is controversial. One model suggests that
the role of the cSMAC depends on antigen quality
and can both enhance signaling and receptor down-
regulation, whereas a second model proposes that
the sole function of the cSMAC is to downregulate
signaling. An important distinction between the
models is whether signaling occurs in the cSMAC.
Here, we demonstrate that at early time points, sig-
naling occurs outside the cSMAC, but occurs in the
cSMAC at later time points. Additionally, we show
that cSMAC formation enhances the stimulatory po-
tency of weak agonists for the TCR. Combined with
previous studies showing that cSMAC formation de-
creases the signaling by strong agonists, our data
support a model proposing that signaling and recep-
tor degradation both occur in the cSMAC and that the
balance between signaling and degradation in the
synapse is determined by antigen quality.
INTRODUCTION
The immunological synapse refers to the contact surface be-
tween the T cell and the antigen-presenting cell (APC) (Grakoui
et al., 1999; Monks et al., 1998). In some cases, there is a reorga-
nization of membrane proteins at the contact surface with pro-
teins such as the T cell receptor (TCR), CD2, CD4, and CD8mov-
ing to a central zone known as the central supramolecular
activation complex (cSMAC) (Monks et al., 1998). The cSMAC
is surrounded by the peripheral SMAC (pSMAC), defined by
the aggregation of the adhesion molecule LFA-1 and its ligand
ICAM-1 (Monks et al., 1998). The functional significance of this
highly specializedmolecular patterning at the T cell-APC contact
site has been controversial (O’Keefe et al., 2004; Varma et al.,
2006; Yokosuka et al., 2005).414 Immunity 29, 414–422, September 19, 2008 ª2008 Elsevier Inc.Originally, it was proposed that the concentration of receptors
and ligands in the contact area would function to enhance re-
ceptor engagement and boost signaling (Grakoui et al., 1999).
This idea is supported by the findings of many groups that a va-
riety of signaling molecules (PKC-q, Lck, ZAP70, Bcl-10, and
PIP3) are also recruited to the cSMAC (Costello et al., 2002;
Freiberg et al., 2002; Huppa et al., 2003; Monks et al., 1998;
Schaefer et al., 2004; Stinchcombe et al., 2001). However, the
finding that the peak of signaling occurs before cSMAC forma-
tion and the relative decrease in phosphorylated tyrosine resi-
dues in the cSMAC (Lee et al., 2002) suggested that the function
of the cSMAC is mainly to facilitate receptor degradation. A
purely degradative role for the cSMAC received support from
single molecule studies using lipid bilayers that showed that
TCRs first engage their ligands in the pSMAC, thereby forming
small signaling clusters that then move to the center of the
contact where there is a paucity of active signaling molecules
(Varma et al., 2006; Yokosuka et al., 2005). This has led to
some confusion in the field about the exact role of the cSMAC.
We have tried to shed light on how the cSMAC regulates sig-
naling and degradation by using computational methods to help
interpret experimental results (Cemerski et al., 2007; Lee et al.,
2003). These studies, using a Monte-Carlo simulation that did
not make any a priori assumption about where signaling or deg-
radation occurred, suggested that the function of the cSMAC
would vary depending on the quality of the peptide-MHC ligand
(Cemerski et al., 2007). For strongly stimulatory pMHC ligands,
the model suggested that TCR triggering was not enhanced by
cSMAC formation and that signaling would occur primarily
outside of the cSMAC; under these conditions, the model
suggested that concentrating molecules in the cSMAC would
primarily enhance degradation, and we confirmed this experi-
mentally (Cemerski et al., 2007). In the case of weak peptides,
however, the model suggested that concentrating receptors
and key signaling molecules in the cSMAC could enhance sig-
naling and, thus, enhance the stimulatory potency of weak ago-
nists. When we simulated amodel in which the cSMAC functions
only to degrade TCRs, we found that if that was the case, cSMAC
formation should always inhibit signaling, regardless of pMHC
ligand quality (Cemerski et al., 2007).
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on two issues: whether signaling occurs in the cSMAC and
whether cSMAC formation could enhance or inhibit the response
to weak ligands. We have also tried to reconcile different studies
by varying the concentration of antigen tested and analyzing our
data at different time points. Our studies suggest that the role of
the cSMAC changes depending on antigen quality, on antigen
dose, and on at what time the analysis is performed. These stud-
ies suggest that the regulation of cSMAC formation may play an
important role in the immunological response in both health and
disease.
RESULTS
Detection of Tyrosine Phosphorylation
in the cSMAC with Lower Doses of Peptide
It has been suggested that TCRs do not signal in the cSMAC
(Campi et al., 2005; Varma et al., 2006; Yokosuka et al., 2005).
This idea is based on the finding that the intensity of signaling de-
tected by staining with antibodies to phosphotyrosine showed
lower staining in the cSMAC as compared to the pSMAC (Lee
et al., 2003). In addition, single-molecule tracking studies con-
firm that signaling intermediates are more prevalent in the
pSMAC and are less abundant in the cSMAC (Varma et al.,
2006; Yokosuka et al., 2005). Nevertheless, although the
absence of TCR signaling in the cSMAC could explain this
data, another explanation is that the low amount of tyrosine
phosphorylation detected in the cSMAC is because the rate of
downregulation of receptors and signaling components (Cemer-
ski et al., 2007; Lee et al., 2003) is masking the signaling events.
We reasoned, therefore, that if we could slow down TCR down-
regulation, we might reveal whether signaling can occur in the
cSMAC.
Because TCR downregulation is related to the dose of antigen
(Hemmer et al., 1998; Itoh et al., 1999), we first tested whether
signaling can be detected in the cSMAC under conditions in
which lower, but still stimulatory, doses of antigenic peptide
are used to stimulate T cells from AND TCR transgenic mice
that recognize a peptide from moth cytochrome c (Kaye et al.,
1989). Previous studies showing low tyrosine phosphorylation
in the cSMAC used planar lipid bilayers pulsed with 100 mM
MCC (Lee et al., 2003), so this dosewas used as the starting con-
centration, with decreasing amounts tested. Cells were flowed
onto the lipid bilayers and after 60 min, fixed, permeabilized,
and stained for tyrosine phosphorylation. For each peptide con-
centration, tyrosine phosphorylation at the cSMAC was scored
and presented as the ratio between phosphorylation in the
cSMAC and the pSMAC. Consistent with a previous observation
(Lee et al., 2003), T cells stimulated on lipid bilayers loaded with
100 mM peptide showed less phosphotyrosine staining in the
cSMAC, as compared to the pSMAC (Figures 1A and 1B). As
the peptide dose was lowered, the ratio of phosphotyrosine
staining between the cSMAC and the pSMAC gradually in-
creased. At the 3 mM peptide dose, there was significantly
more phosphotyrosine staining in the cSMAC as compared to
the pSMAC (Figures 1A and 1B).
Because the 60 min time point we chose is much later than
time points used by others (Campi et al., 2005; Yokosuka
et al., 2005), we analyzed the ratio of phosphotyrosine betweenImthe cSMAC and pSMAC, after 15, 30, and 45 min upon 3 mM
MCC stimulation. As shown in Figure 1C, although the ratio of
phosphotyrosine staining favored the pSMAC at early time
points, over time the ratio of phosphotyrosine in the cSMAC to
that in the pSMAC increased.
We confirmed the above data obtained with lipid bilayers by
also stimulating T cells conjugated with peptide-pulsed APCs.
We could easily detect staining for phosphorylated tyrosine in
cSMACs, and this appeared to be related to antigen dose
(Figure 2).
Because tyrosine phosphorylation is potentially mediated by
receptors other than the TCR, we validated our results with an
antibody specific to phosphorylated ZAP-70, a signaling inter-
mediate downstream of the TCR. Similar to our results obtained
with the phosphotyrosine antibody, at low peptide doses, stain-
ing with an antibody to phosphorylated ZAP-70 revealed strong
Figure 1. Detection of Tyrosine Phosphorylation in the cSMAC with
Low Doses of Peptide
(A) Naive CD4+ T cells were isolated from spleens of ANDmice, stimulated with
MCC-loaded, irradiated B10.BR splenocytes for 5 days and used on day 6.
The rested AND T cells were flowed over lipid bilayers loaded with the indi-
cated doses ofMCC for 1 hr after which the bilayers were fixed, permeabilized,
and stained with an antibody to phosphotyrosine. The images are representa-
tive of over 50 cells obtained in three independent experiments.
(B) Phosphotyrosine staining in the cSMAC and pSMAC of more than 50 cells
obtained in three independent experiments was measured with ImageJ soft-
ware and represented as the ratio between phosphotyrosine staining in the
cSMAC compared to that in the pSMAC.
(C) T cells were allowed to form mature synapses for 15, 30, or 45 min on lipid
bilayers loaded with 3 mMMCC. The bilayers were stained and quantitated as
described above. The graphs show means ± SD of 3 independent experi-
ments. We obtained p values (*p < 0.05; **p < 0.01) by using the Student’s
t test.munity 29, 414–422, September 19, 2008 ª2008 Elsevier Inc. 415
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Evidence of Signaling from the cSMACFigure 2. Detection of Tyrosine Phosphory-
lation in T Cell-APC Conjugates
(A) Rested AND T cells were stimulated with CH27
cells loaded with the indicated amounts of peptide
for 1 hr. Conjugates were then fixed, permeabi-
lized, and stained with antibodies to Vb3 and phos-
photyrosine. The images are representative of
over 20 conjugates obtained in two independent
experiments.
(B) Phosphotyrosine staining in the cSMAC was
measured with ImageJ software and represented
as the percentage of cells in which phosphotyro-
sine staining in the cSMAC was at least 1.5-fold
greater compared to the pSMAC (the area of the
contact site excluding the cSMAC). Conjugates
in which Vb3 accumulation in the central third of
the contact site was at least 1.5 times greater
than at the rest of the contact site were considered
to have cSMACs. The graph shows the mean of
two independent experiments.ZAP-70 phosphorylation in the cSMAC (Figure 3). We confirmed
that this lower dose of peptide was still able to stimulate a strong
proliferative response. In addition, calcium measurements of
cells attached to antigen-loaded APCs showed that both peptide
doses were able to stimulate similar amounts of calcium mobili-
zation. Interestingly, we did note that the calcium profile of cells
stimulated with the lower peptide dose displayed a lower initial
calcium spike and a more oscillatory nature of the sustained
phase of calcium mobilization as compared to cells stimulated
with a higher dose of peptide (Figure S1 available online).
Thus, when antigen quantity is reduced and, in particular, at later
time points, tyrosine-phosphorylated proteins and phosphory-
lated ZAP-70 are readily detectable in the cSMAC.
Pharmacological Inhibition of TCR Internalization
Enhances Phosphotyrosine Staining in the cSMAC
The results above are consistent with our previous study that
suggested that the inability to detect signaling intermediates in
the cSMACmight be due to rapid internalization and degradation
of the TCR (Lee et al., 2003). Therefore, we wanted to test
whether pharmacological inhibition of TCR internalization and
downregulation would enhance phosphotyrosine staining in the
cSMAC. We first confirmed that chlorpromazine, an inhibitor of
clathrin-mediated internalization (Wang et al., 1993), was capa-416 Immunity 29, 414–422, September 19, 2008 ª2008 Elsevier Inc.ble of inhibiting TCR downregulation in AND T cells conjugated
with MCC pulsed-CH27 cells (Figure 4A). We then tested the ef-
fects of chlorpromazine treatment on the pattern of phosphotyr-
osine staining of AND T cells incubated on bilayers pulsed with
100 mM MCC peptide. Cells were pretreated for 20 min with
chlorpromazine, incubated on peptide-loaded lipid bilayers,
and stained for phosphotyrosine 60 min later. Although cSMACs
of untreated cells showed very little phosphotyrosine content,
cells treated with chlorpromazine showed a significant increase
in the phosphotyrosine signal in the cSMAC (Figures 4B and 4C).
This is consistent with our hypothesis that, for strong ligands, en-
hanced TCR downregulation in the cSMAC limits the ability to
detect phosphotyrosine there.
Accumulation of Fully Phosphorylated
TCR-z at the cSMAC
If concentrating TCRs in the cSMAC functions to both enhance
signaling and subsequent downregulation, we reasoned that
the intensity of tyrosine-phosphorylated TCRs should be higher
in the cSMAC as compared to the pSMAC. The TCR-z chain
has six different tyrosines, and it has been reported that the effi-
ciency of z chain phosphorylation is related to the strength of re-
ceptor engagement, with weak stimuli resulting in partially phos-
phorylated TCR-z chains and strong stimuli resulting inmore fullyFigure 3. PhosphorylatedZAP70 IsDetected
in the cSMAC
(A) Naive CD4+ T cells were isolated from spleens
of ANDmice and prepared as described in Figure 2
except that anti-phospho-319 ZAP-70 was used.
The images are representative of over 50 cells
obtained in three independent experiments.
(B) The localization of anti-phospho-319 ZAP-70
staining of the bilayers in (A) was measured with
ImageJ software and represented as the ratio
between phospho-319 ZAP-70 staining in the
cSMAC compared to that in the pSMAC. The
graph shows the means ± SD obtained in three in-
dependent experiments. We obtained the p value
(*p < 0.01) by using the Student’s t test.
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Downregulation Enhances Phosphotyro-
sine Detection in the cSMAC
(A) Rested AND T cells were preincubated with the
indicated doses of chlorpromazine for 20 min and
stimulated with unpulsed or 10 mM MCC-pulsed
CH27 cells. To measure TCR downregulation, we
disrupted cell conjugates with trypsin-EDTA,
stained them with anti-Vb3 and analyzed them
by flow cytometry for surface TCR expression.
TCR expression is shown as the percentage of
TCR expression as compared to T cells stimulated
with unpulsed CH27 cells. The data are represen-
tative of three independent experiments.
(B) Rested untreated or chlorpromazine-treated
(20 mg/ml) ANDT cells were flowed on lipid bilayers
loaded with 100 mM MCC. After 1 hr, the bilayers
were fixed, permeabilized, and stained with an
antibody to phosphotyrosine. The images shown
are representative of over 50 cells analyzed in
three independent experiments.
(C) Phosphotyrosine staining in the cSMAC and
pSMAC of more than 50 cells obtained in three
independent experiments was measured with
ImageJ software and represented as the ratio be-
tween phosphotyrosine staining in the cSMAC as
compared to the pSMAC. The graph shows the
means ± SD obtained in three independent exper-
iments. We obtained p values (*p < 0.001) were
obtained by using the Student’s t test.phosphorylated TCR-z chains (Madrenas et al., 1995; Sloan-Lan-
caster et al., 1994). We took advantage of previous data showing
that the six tyrosines are phosphorylated in a specific order
(Kersh et al., 1998a) to test the hypothesis that the cSMACwould
function to enhance the efficiency of z chain phosphorylation.
Specifically, it was shown that the second tyrosine of the second
ITAM (the B2 tyrosine) is the last tyrosine to be phosphorylated
when the fully phosphorylated (p23) TCR-z chain is generated
(Kersh et al., 1998a), whereas the first tyrosine of the second
ITAM (the B1 tyrosine) is phosphorylated in the partially phos-
phorylated (p21) TCR-z chain. We reasoned that the difference
in the localization of partially and fully phosphrylated TCR-z
chains in the immunological synapse could be used to determine
where the strongest area of signaling occurs.
Phospho-specific antibodies were raised in rabbits with pep-
tides containing the phosphorylated B1 andB2 tyrosines, as previ-
ously described (Kersh et al., 1998a). To confirm the specificity of
these antibodies, we tested whether they could detect tyrosine
phosphorylation of a chimeric wild-type (WT) or a mutated TCR-z
chain with the B1 and B2 tyrosines changed to phenylalanine ex-
pressed inHeLacells (Figure5A) (TimsonGauenetal., 1992). Treat-
ment of cellswithpervanadate (a tyrosinephosphatase inhibitor) or
cotransfection with Lck, demonstrated that the antibodies de-
tected phosphorylated z only if the specific B1 or B2 tyrosine was
intact (Figure 5A). This confirmed the specificity of the antibodies.
The location of TCR-z chains phosphorylated on B1 and B2
was assessed by immunofluorescence staining in AND T cells in-
cubated on planar lipid bilayers or with peptide-pulsed APCs
loaded with 100 mM or 20 mM MCC. We scored synapses into
three categories depending on whether staining was mainly in
the cSMAC, the pSMAC, or if it was evenly distributed between
the two. In the majority of synapses, the B1 antibody stainedImmainly the pSMAC or was evenly distributed between the two
(Figure 5B). In contrast, anti-B2 reactivity was found to be pref-
erentially localized to the cSMAC in the synapses formed both
between lipid bilayers and APCs (Figures 5B and 5C). The differ-
ential staining pattern between the two antibodies supports the
idea that the amount of phosphorylated TCR-z is different in
the cSMAC versus the pSMAC and is consistent with the idea
that the highest intensity signaling occurs in the cSMAC.
Accumulation of PIP3 at the cSMAC
The production of the lipid PIP3 has been shown to be dependent
on TCR signaling and, because it has a short half-life, should
closely correlate with the location of active TCR signaling (Cost-
ello et al., 2002; Harriague and Bismuth, 2002; Huppa et al.,
2003). We reasoned that if the cSMAC was an area of active sig-
nal transduction, we might expect it to also be a location where
PIP3 is produced. To assess where in the immunological syn-
apse PIP3 was being produced, we used a retrovirus expressing
the PH domain of AKT fused to GFP (Giurisato et al., 2007) to fol-
low the production of PIP3 in the synapse. At early time points,
little to no enrichment of this marker was seen in the cSMAC
(Figure 6A). However, after 1 hr, a clear enrichment of the probe
in the cSMACs was seen (Figures 6A and 6B and Figure S2),
a finding consistent with previously published studies (Costello
et al., 2002; Huppa et al., 2003). Because of the short half-life
of PIP3 (Costello et al., 2002), this suggests that the major site
of production, at later time points, is in the cSMAC.
Enforced cSMAC Formation Increases the Stimulatory
Capacity of Weak Peptides
Our computational model of cSMAC function predicted that
cSMAC formation has different effects depending on whethermunity 29, 414–422, September 19, 2008 ª2008 Elsevier Inc. 417
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Evidence of Signaling from the cSMACthe peptide quality is strong or weak (Cemerski et al., 2007). Pre-
viously, we took advantage of our finding that engagement of the
receptor NKG2D can induce cSMAC formation regardless of
whether antigen is present (Cemerski et al., 2007; Markiewicz
et al., 2005). By transducing CD4+ AND T cells with NKG2D and
APCs with a ligand for NKG2D, we could assess the response
of T cells in which cSMAC formation was strongly enhanced. Us-
ing this system, we showed previously that NKG2D-mediated
cSMAC formation inhibits signaling mediated by strong agonists
(Cemerski et al., 2007). We were, however, unable to assess the
response to weak peptides in that study because weak peptides
are not known for the AND TCR. We therefore, turned to T cells
from the 5C.C7 (Seder et al., 1992) and the 3L2 (Kersh et al.,
1998b) transgenic mice because well-characterized weak ago-
Figure 5. Localization of Fully Phosphory-
lated TCR-z at the cSMAC
(A) Schematic diagram showing the nomenclature
of the six tyrosines in the z chain and the position
of the B1 and B2 tyrosines that were mutated.
HeLa cells, transfected with the indicated z chime-
ric constructs, were lysed without stimulation (left
panel) or after a 10 min treatment with pervana-
date (middle panel). The right panel shows cells
lysates from cells coexpressing the indicated chi-
meric z construct with Lck. Lysates were resolved
by SDS-PAGE transferred to nitrocellulose
membranes and immunoblotted with the a-B1
and a-B2 rabbit antisera.
(B) Rested AND T cells were allowed to adhere
for 40–60 min on planar lipid bilayers loaded with
100 mM of wild-type MCC peptide. Cells were
fixed, permeabilized, and stained with a-B1 and
a-B2 antisera. Cells were scored and classified
into three groups (predominant staining of the
cSMAC, pSMAC, or relatively even staining
between cSMAC and pSMAC). Representative
images of pSMAC-dominant, cSMAC-dominant,
or both pSMAC- and cSMAC-dominant staining
are shown. Images were quantitated with ImageJ
software, in over 20 images obtained in at least
two independent experiments, and represented
as the percentage of cells showing one of the three
patterns of staining.
(C) AND T cells were stimulated with CH27 cells
loaded with the 20 mM MCC peptide for 1 hr then
fixed, permeabilized, and stained with anti-Vb3
and the B2 antibody. The image shown is repre-
sentative of over 40 cells obtained in three inde-
pendent experiments. The localization on anti-B2
staining was quantified in the cells that formed
cSMACs (on the basis of anti-Vb3 staining) and
expressed as the percentage of cells having
a pSMAC-enriched (empty bars), cSMAC-en-
riched (black bars), or equally pSMAC- and
cSMAC-enriched (gray bars) B2 staining.
nist peptides are defined for both of these
TCRs (Kersh and Allen, 1996; Kersh et al.,
1998c; Lyons et al., 1996; Reay et al.,
1994; Wulfing et al., 1997).
5C.C7 and 3L2 T cells were retrovirally
transduced with cDNAs for NKG2D and
a YFP-tagged form of the signaling adaptor, DAP10 (Giurisato
et al., 2007), and purified by cell sorting. Expression and coas-
sembly of NKG2D with DAP10 is required for its plasma-mem-
brane expression (Wu et al., 1999). The proliferative response
of the transduced T cells to the wild-type as well as to a range
of weak peptides, T102S and K99A in the 5C.C7 system and
C72 and T72 in the 3L2 system, was then tested. Consistent
with our previous findings that enforced cSMAC formation in-
hibits strong peptides (Cemerski et al., 2007), the proliferative re-
sponse of 5C.C7 T cells to the wild-type peptide was decreased
in the presence of NKG2D (Figure 7A). Importantly, however, the
proliferative response of transduced 5C.C7 T cells to weaker
peptides, T102S and K99A, was increased in the presence of
NKG2D engagement and increased cSMAC formation418 Immunity 29, 414–422, September 19, 2008 ª2008 Elsevier Inc.
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(Figure S3).
We confirmed that NKG2D engagement enhanced TCR en-
gagement and signaling by measuring TCR downregulation.
The efficiency of TCR downregulation is thought to be directly re-
lated to agonist quality with better agonist quality resulting in
more TCR downregulation (Hemmer et al., 1998; Itoh et al.,
1999). TCR expression was measured by flow cytometry before
and after stimulation with WT and K99A MCC peptides. NKG2D
expression resulted in increased TCRdownregulation in bothWT
and K99A MCC-stimulated AND T cells (Figure 7B). We also
compared calcium mobilization of WT and NKG2D and
DAP10-expressing T cells after stimulation with WT and weaker
peptides. We found that the presence of NKG2D depressed the
initial calcium spike but resulted in a more stable sustained
phase of calcium mobilization (Figures S4 and S5). Thus, the
presence of NKG2D does not appear to lead to a generalized en-
hancement of activation parameters but, rather, results in quali-
tative changes in signaling that affect the proliferative profile.
DISCUSSION
The function of the cSMAC in the immunological synapse has
been controversial (Cemerski and Shaw, 2006; Kupfer, 2006; Lin
et al., 2005). Although it was originally proposed that its purpose
was to enhance signaling by the TCR (Grakoui et al., 1999), the
finding that the cSMAC forms after the peak of measurable tyro-
sine phosphorylation (Lee et al., 2002) and the distinctly lower
levels of tyrosine phosphorylation detected in the cSMAC (Lee
et al., 2003) suggested that the cSMAC does not function to en-
hance TCR signaling. Supporting this idea is the finding that
CD2AP-deficient cells that cannot form cSMACs have hyperproli-
ferative responses (Lee et al., 2003). In addition, studies using
single-molecule tracking showed that TCRs initiate signaling by
formingmicroclusters in thepSMAC (Varmaetal., 2006;Yokosuka
et al., 2005). Thus, the current model is that the cSMAC has no
Figure 6. PI3 Kinase Activity Is Enriched at
the cSMAC
CD4+ T cells were purified from spleens from AND
TCR transgenic mice and retrovirally transduced
with the PH-AKT-GFP biosensor (Giurisato et al.,
2007). GFP-positive cells were sorted and then
incubated for 1 hr on lipid bilayers loaded with
100 mMMCCpeptide (A) or with CH27 cells loaded
with 20 mM MCC (B). Images shown here are rep-
resentative of over 20 images obtained in at least
two independent experiments.
signaling function and most likely repre-
sents a structure that forms to enhance
the internalization and degradation of
phosphorylated proteins and receptors
(Varma et al., 2006; Yokosuka et al., 2005).
Our previous work, however, sug-
gested that a degradative role for the
cSMAC might be dependent upon the
quality of the peptide (Cemerski et al.,
2007). Mathematical modeling suggested
that when peptide quality is high (has a long half-life), receptors
can engage and become phosphorylated without requiring
clustering or requiring concentration in the cSMAC. However,
because downregulation of receptors requires ubiquitination
and because receptor ubiquitination involves the recruitment of
enzymes from the cytosol to the membrane (Jang and Gu,
2003), concentrating phosphorylated receptors in the cSMAC
will enhance both enzyme recruitment and ubiquitination. The
model predicted that in the case of weak peptides (short half-
lives), receptor engagement and phosphorylation in the absence
of the concentrating effect of cSMAC formation would be rela-
tively inefficient and should be enhanced upon concentrating
TCR and pMHC ligands in the cSMAC. Because these ligands
are not strong enough to result in strong tyrosine phosphoryla-
tion of the receptor, the effect of cSMAC formation is less on
receptor downregulation compared to its ability to enhance
signaling. A compelling feature of this model is the ability to
explain the effect of cSMAC formation on receptor degradation
without invoking the assumption that the cSMAC is a specialized
degradative structure.
The key distinguishing feature between a model in which the
cSMAC functions to only facilitate receptor degradation and
a model in which the cSMAC enhances signaling and degrada-
tion is whether formation of the cSMAC functions always inhibits
signaling or whether the cSMAC inhibits or enhances signaling
depending on whether the agonist is strong or weak, respec-
tively (Cemerski et al., 2007). Inherent to the second model is
the ability of signaling to occur in the cSMAC.
Using cells transduced with NKG2D and DAP10, we assessed
the role of cSMAC formation on a range of weak peptides. Pre-
viously, we found that engagement of NKG2D could stimulate
the formation of immunological synapses with cSMACs inde-
pendently of whether antigen was present or not (Markiewicz
et al., 2005). We used this manipulation to show that enforced
cSMAC formation could inhibit signaling by strong peptides in
the AND TCR system (Cemerski et al., 2007). Here, we extendedImmunity 29, 414–422, September 19, 2008 ª2008 Elsevier Inc. 419
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Evidence of Signaling from the cSMACFigure 7. cSMAC Formation Increases the
Stimulatory Potency of Weak Peptides
(A) NKG2D-induced cSMAC formation enhances
the recognition of weak peptides. 5CC7 CD4+
T cells were retrovirally transduced with NKG2D
and DAP10-YFP. Cells that were either positive
for both NKG2D and DAP10 or negative for the ex-
pression of these proteins were sorted and stimu-
lated with CH27 cells transduced with Rae13
loaded with the indicated peptides. Proliferative
responseswere assessed by [3H]-thymidine incor-
poration during the last 16 hr of a 72 hr stimulation
and expressed in cpm. The results shown are
representative of three experiments.
(B) Increased NKG2D-mediated TCR downregula-
tion. WT and NKG2D-and-DAP10-transduced AND T cells were stimulated for 3 hr with Rae-13-expressing CH27 cells unpulsed or pulsed with 20 mM of the
indicated peptides. After 3 hr, cells were stained for Vb3 expression and TCR expression levels analyzed by flow cytometry. The result shown is a representative
of two independent experiments.these previous studies to show that expression of NKG2D on the
5C.C7 and 3L2 T cells resulted in enhanced recognition of weak
peptides. The ability of NKG2D-induced enhancement of
cSMAC formation to both inhibit signaling to strong peptides
and enhance signaling to weak peptides supports the hypothe-
sis that the cSMAC functions differently for peptides of different
potencies. It also suggests that the effects of NKG2D are not re-
lated to a general effect of NKG2D signaling on T cell activation.
We were surprised to find that the effect of NKG2D synapse
formation on downstream pathways is not straightforward. We
expected that downstream signals such as themagnitude of cal-
cium fluxes would reflect the enhanced or inhibited activation
parameters but found instead that the changes induced by
NKG2D-mediated synapse formation were more complex with
changes in the magnitude of the initial calcium flux as well as
the slope of the sustained phase. Clearly, more work is needed
to understand how synapse formation is related to both themag-
nitude of signaling and how it is sustained.
The observation that cSMAC formation enhances the stimula-
tory potency of weak ligands is predicated on the occurrence of
signaling in the cSMAC. We tested this hypothesis directly. We
found that T cell stimulation under conditions of reduced recep-
tor internalization, achieved by using lower antigen doses as well
as pharmacological inhibitors of internalization, resulted in en-
hanced detection of tyrosine phosphorylation in the cSMAC.
More compelling was the data measuring PIP3 production in
the synapse. Because PIP3 has a relatively short half-life in
T cells, it is dependent on TCR engagement and is confined to
the plasma membrane (Costello et al., 2002; Huppa et al.,
2003). Therefore, the production of PIP3 can be used as a rela-
tively good surrogate for TCR signaling. Our finding that PIP3 is
largely confined to the cSMAC is consistent with the idea that
at late time points, TCR engagement in the cSMAC is largely re-
sponsible for PIP3 production. These findings also seem to be
consistent with images published by others using the same
AKT-PH domain probe (Costello et al., 2002; Huppa et al., 2003).
In addition, our finding that fully phosphorylated TCR-z chains
are preferentially found in the cSMAC also supports a model in
which the cSMACenhances signaling. Although it iswell accepted
that the six tyrosines in TCR-z are phosphorylated in a specific or-
der, there has been some controversy about which tyrosine is
phosphorylated last. This is important because a reagent recog-420 Immunity 29, 414–422, September 19, 2008 ª2008 Elsevier Inc.nizing this tyrosine would be a specific marker for fully phosphor-
ylated TCR-z. Using phosphospecific antibodies, Kersh et al.
(1998a) found that the B2 tyrosine was phosphorylated last,
whereas van Oers et al. (2000) found using mass spectrometry
that it was the A2 tyrosine. Our results showing distinct staining
of B1 as compared with that of B2 antibodies are consistent with
the B2 being foundmainly in fully phosphorylated TCR-z and sup-
port the findings of Kersh et al. We tested an A2-specific antibody
defined by immunoblotting, but it was unable to stain cells. Be-
cause the study by Van Oers et al. was performed with TCR-z pu-
rified fromhuman thymus, it is possible that thedifference isdue to
differences in developing T cells versus peripheral T cells or could
be due to differences between mouse and human T cells.
One important difference between our experiments and previ-
ous studies may be the late time point that we used. In all of our
experiments, we fixed cells after 60 min, a time point well after
the cSMAC has formed (Lee et al., 2003). Indeed, we observed
tyrosine phosphorylation predominantly in the pSMAC as re-
ported by others (Mossman et al., 2005), even when we used
the lower peptide dose, at earlier time points. As time passed,
we saw that gradually more and more signaling was detectable
in the cSMAC. Although the formation of TCR microclusters in
the periphery of the contact is likely in the early stages of syn-
apse formation before the cSMAC has formed, how TCR signal-
ing is maintained for hours after the cSMAC is not clear (Iezzi
et al., 1998). Given the low abundance of antigenic peptides
likely to be present on APCs in vivo (Harding and Unanue,
1990; Irvine et al., 2002), it is difficult to imagine how enough ag-
onist peptide could be present to continuously prime the forma-
tion of TCR microclusters in the pSMAC for the many hours that
would be required if signaling could only occur in the pSMAC. A
model that allows for signaling in the cSMAC can explain how
signaling by a few antigenic peptides is sustained by positing
that the few agonist peptides trapped in the cSMAC can repeti-
tively trigger TCRs for hours (Valitutti et al., 1995). This model
also suggests that concentrating endogenous pMHC complexes
in the cSMAC could also contribute to the longevity of TCR en-
gagement and signaling in combination with agonist peptides
(Krogsgaard et al., 2005). Our in silico and in vitro studies
suggest that the cSMAC is a versatile structure that can both
enhance signaling and receptor degradation in a manner that
depends upon antigen quality.
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Mice
AND TCR transgenic mice (B6;SJL-Tg(TcrAND)53Hed/J) and B10.BR mice
(B10.BR-H2k H2-T18a/SgSnJ) were purchased from The Jackson Laboratory.
5C.C7 TCR transgenic mice (5C.C7 TCRtg RAG-2/ H-2a) were obtained
from Taconic Farms. 3L2 TCR transgenic mice were generated previously
by P. Allen (Kersh et al., 1998b). Mice were maintained under pathogen-free
conditions in the Washington University animal facilities in accordance with
institutional guidelines.
Peptides
Wild-type and mutated moth cytochrome C (MCC) peptides 88–103 and he-
moglobin peptides 65–74 were synthesized with standard F-Moc chemistry.
The peptides were purified to homogeneity by reverse-phase HPLC, and their
composition was confirmed by mass spectrometry and amino acid analysis
(Washington University Mass Spectrometry Facility, St. Louis, MO, USA).
Antiserum to Phospho-TCR-z
Rabbit antisera were raised against the phosphotyrosine-containing peptides
MGGKQQRRRDPQEGV(PO4)YNALQKDKMAEA and NALQKDKMAEA(PO4)
YSEIGTKGERRRGKGH, corresponding to the first and second tyrosines of
the second ITAM motif of TCR-z (Biosource). The antisera were absorbed
against the unphosphorylated peptide and then affinity purified with the phos-
phorylated peptide.
T Cell Purification
For purification of splenic T cells, splenocytes were depleted of CD8+, MHC-
class II-positive and immunoglobulin-positive cells by antibody-mediated
nanoparticle negative selection (EasySep CD4+ negative-selection cocktail,
StemCell Technologies). The CD4+ T cells were stimulated for 4 days with irra-
diated B10.BR splenocytes andMCCpeptide, rested for 2 days, and thereafter
used. For the experiments involving chlorpromazine, the cells were incubated
with 15 mg/ml of chlorpromazine for 20 min, washed, and immediately used.
TCR Downregulation
AND T cells were stimulated for 2 hr, at a 1:1 ratio, with peptide pulsed or un-
pulsedCH27 I-Ek cells. Upon stimulation, cells were lightly pelleted and treated
with trypsin-EDTA to break cell conjugates, washed, and labeled with FITC-
conjugated anti-CD4 and PE-conjugated Vb3 antibodies (BD PharMingen).
Vb3 surface expressionwas assessed by flow cytometry (FACScan, BDBiosci-
ences) on CD4-positive gated cells. Data were analyzed by WinMDI 2.8 soft-
ware (http://facs.scripps.edu/software.html) or CellQuest (BD PharMingen).
Transfection
The construct encoding Gz, a previously described z chimeric molecule (Tim-
son Gauen et al., 1992), composed of the extracellular domain of the vesicular
stomatitis virus glycoprotein (VSV G) and the transmembrane and cytoplasmic
region of mouse TCR-z, was subjected to site-directed mutagenesis (Strata-
gene) for obtaining mutated constructs of Gz in which the codons encoding
Y90 and Y102 were changed to phenylalanine.
HeLa cells were transfected withWT andmutant forms of Gzwith a transient
expression system (Timson Gauen et al., 1992). In brief, cells were infected
with a recombinant vaccinia virus encoding a bacteriophage T7 RNA polymer-
ase for 30 min; this infection was followed by CLONfectin (BD Biosciences
Clontech)-mediated transfection with plasmids encoding the Gz constructs.
Cell Lysis, Immunoprecipitation, and Immunoblotting
Transfected HeLa cells were lysed for 10 min on ice in 1% NP-40 containing
lysis buffer and cleared by centrifugation. Postnuclear supernatants were re-
solved on SDS-PAGE under reducing conditions, transferred to nitrocellulose
membranes, and immunoblotted with the anti-B2 or anti-VSV antisera. Blots
were visualized with the ECL western blotting kit (Pierce).
Retroviral Transduction
The Plat E ecotropic packaging cell line (Morita et al., 2000) was transfected
with a PH-AKT-GFP retroviral construct or a mixture of NKG2D and DAP10-
YFP retroviral constructs. Purified CD4 T cells were stimulated with irradiatedB10.BR splenocytes and the antigenic peptide. At 18 and 42 hr after stimula-
tion, T cells were incubated for 4 hr with the viral supernatants and then centri-
fuged for 45 min in the presence of Lipofectamine 2000 (Invitrogen). On day 4
after stimulation, cells were sorted with a FACSVantage flow sorter (BD Biosci-
ences) at the Washington University Pathology Cell Sorting Facility. For
NKG2D/DAP10-YFP double transduction, cells were stainedwith a PE-labeled
NKG2D antibody and YFP-and-PE-positive and YFP-and-PE-negative cells
were sorted and used for further experimentation.
T Cell Proliferation Assays
NKG2D/DAP10-positive and -negative CD4+ AND, 5C.C7, or 3L2 T cells were
stimulated for 48 hr with mitomycin-treated CH27 cells expressing Rae-13 and
various amounts of peptides, pulsed with 1 mCi of [3H] thymidine/well, and
harvested 16 hr later, with scintillation counted.
IS and cSMAC Formation
Sorted retrovirally transduced AND T cells were incubated with peptide loaded
or unloaded CH27 I-Ek cells for 30 min. Cells were then fixed and mounted on
coverslips, and confocal images taken with a Zeiss LSM510 confocal micro-
scope. Unprocessed images were scored for cSMAC formation and accumu-
lation of tyrosine-phosphorylated proteins at the cSMACwith ImageJ software
(NIH, Bethesda, Maryland, http://rsb.info.nih.gov/ij/, 1997–2006). Conjugates
were scored as cSMAC positive or phosphotyrosine at the cSMAC positive
if the central third of the contact area showed a 1.53 enrichment of Vb3 (for
cSMAC scoring) or phosphotyrosine (scored in cSMAC-positive conjugates)
compared to the rest of the contact site.
Lipid-Bilayer Preparation
Planar lipid bilayers were made by mixing Cy5-labbeled ICAM1-containing
liposomes (generously provided by T. Saito, RIKEN, Japan) and I-Ek containing
liposomes, in a 1:1 ratio, on clean glass coverslips in a parallel plate flow cell
(Bioptechs). I-Ek molecules were loaded overnight by flowing the indicated
amount of WT MCC peptide over the bilayer. Rested CD4+ AND T cells were
injected into the warmed (37C) flow cells in HBS with 1% human serum albu-
min (Alpha Therapeutic). After 60 min, cells were fixed by flowing 2% parafor-
maldehyde over the bilayer, permeabilized with 0.05%Triton X-100, incubated
in PBS containing 4% BSA, and stained with the indicated antibodies. Cells
were imaged with a Zeiss LSM510 confocal system. Unprocessed images
were scored, with ImageJ software (NIH, Bethesda, Maryland, http://rsb.
info.nih.gov/ij/, 1997-2006).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and five
figures and can be found with this article online at http://www.immunity.
com/cgi/content/full/29/3/414/DC1/.
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